Found: 15
Select item for more details and to access through your institution.
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40024-3
- By:
- Publication type:
- Article
RHOA<sup>L57V</sup> drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.
- Published in:
- Science Signaling, 2023, v. 16, n. 816, p. 1, doi. 10.1126/scisignal.adg5289
- By:
- Publication type:
- Article
High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors.
- Published in:
- Science Signaling, 2020, v. 13, n. 636, p. 1, doi. 10.1126/scisignal.aay1451
- By:
- Publication type:
- Article
Front Cover: Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity (ChemBioChem 19/2023).
- Published in:
- ChemBioChem, 2023, v. 24, n. 19, p. 1, doi. 10.1002/cbic.202300535
- By:
- Publication type:
- Article
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity.
- Published in:
- ChemBioChem, 2023, v. 24, n. 19, p. 1, doi. 10.1002/cbic.202300141
- By:
- Publication type:
- Article
Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04461-6
- By:
- Publication type:
- Article
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.18970
- By:
- Publication type:
- Article
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-17440-w
- By:
- Publication type:
- Article
Loss of p16[sup Ink4a] with retention of p19[Arf] predisposes mice to tumorigenesis.
- Published in:
- Nature, 2001, v. 413, n. 6851, p. 86, doi. 10.1038/35092592
- By:
- Publication type:
- Article
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51271-3
- By:
- Publication type:
- Article
Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6223, doi. 10.3390/cancers14246223
- By:
- Publication type:
- Article
ARID1B is a specific vulnerability in ARID1A-mutant cancers.
- Published in:
- Nature Medicine, 2014, v. 20, n. 3, p. 251, doi. 10.1038/nm.3480
- By:
- Publication type:
- Article
Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Massively parallel phenotyping of coding variants in cancer with Perturb-seq.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 6, p. 896, doi. 10.1038/s41587-021-01160-7
- By:
- Publication type:
- Article